Fund profile
Fund manager
Total assets
$18.89 mm
Liabilities
$14.75 k
Net assets
$18.88 mm
Number of holdings
47.00
47 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
REGN Regeneron Pharmaceuticals, Inc. | 1.02 mm | 1.05 k shares | 5.38 | Common equity | Long | USA |
MRK Merck & Co Inc | 953.75 k | 7.50 k shares | 5.05 | Common equity | Long | USA |
Daiichi Sankyo Co Ltd
|
738.00 k | 22.24 k shares | 3.91 | Common equity | Long | Japan |
ILMN Illumina Inc | 700.55 k | 5.01 k shares | 3.71 | Common equity | Long | USA |
Novartis AG
|
666.46 k | 6.59 k shares | 3.53 | Common equity | Long | Switzerland |
CRSP CRISPR Therapeutics AG | 621.21 k | 7.38 k shares | 3.29 | Common equity | Long | Switzerland |
AZN Astrazeneca plc | 591.02 k | 4.69 k shares | 3.13 | Common equity | Long | UK |
MREO Mereo Biopharma Group Plc | 571.17 k | 150.31 k shares | 3.03 | Common equity | Long | UK |
Chugai Pharmaceutical Co Ltd
|
565.78 k | 14.14 k shares | 3.00 | Common equity | Long | Japan |
CLDX Celldex Therapeutics Inc. | 563.98 k | 11.74 k shares | 2.99 | Common equity | Long | USA |
ARGX Argen X SE | 521.37 k | 1.37 k shares | 2.76 | Common equity | Long | Netherlands |
GILD Gilead Sciences, Inc. | 521.07 k | 7.23 k shares | 2.76 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 473.12 k | 5.06 k shares | 2.51 | Common equity | Long | USA |
NTLA Intellia Therapeutics Inc | 458.42 k | 14.27 k shares | 2.43 | Common equity | Long | USA |
LEGN Legend Biotech Corp | 454.69 k | 6.98 k shares | 2.41 | Common equity | Long | USA |
RVMD Revolution Medicines Inc | 446.86 k | 15.16 k shares | 2.37 | Common equity | Long | USA |
INCY Incyte Corp. | 445.75 k | 7.64 k shares | 2.36 | Common equity | Long | USA |
BMY Bristol-Myers Squibb Co. | 431.93 k | 8.51 k shares | 2.29 | Common equity | Long | USA |
GH Guardant Health Inc | 411.79 k | 21.67 k shares | 2.18 | Common equity | Long | USA |
BGNE BeiGene Ltd | 410.65 k | 2.48 k shares | 2.18 | Common equity | Long | USA |
EXEL Exelixis Inc | 399.26 k | 18.23 k shares | 2.11 | Common equity | Long | USA |
TXG 10x Genomics Inc - Ordinary Shares | 383.33 k | 8.22 k shares | 2.03 | Common equity | Long | USA |
FUSN Fusion Pharmaceuticals Inc | 375.63 k | 31.41 k shares | 1.99 | Common equity | Long | Canada |
Siemens Healthineers AG
|
370.82 k | 6.18 k shares | 1.96 | Common equity | Long | Germany |
MRUS Merus N.V | 354.05 k | 7.30 k shares | 1.88 | Common equity | Long | Netherlands |
DAWN Day One Biopharmaceuticals Inc | 350.29 k | 20.94 k shares | 1.86 | Common equity | Long | USA |
GMAB Genmab | 336.77 k | 12.13 k shares | 1.78 | Common equity | Long | Denmark |
EXAS Exact Sciences Corp. | 329.01 k | 5.72 k shares | 1.74 | Common equity | Long | USA |
ARVN Arvinas Inc | 320.39 k | 6.97 k shares | 1.70 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals Inc | 309.66 k | 9.58 k shares | 1.64 | Common equity | Long | USA |
DCPH Deciphera Pharmaceuticals Inc | 306.41 k | 18.36 k shares | 1.62 | Common equity | Long | USA |
MRNA Moderna Inc | 304.48 k | 3.30 k shares | 1.61 | Common equity | Long | USA |
SDGR Schrodinger Inc | 300.71 k | 11.81 k shares | 1.59 | Common equity | Long | USA |
CGEM Cullinan Therapeutics Inc | 298.24 k | 16.15 k shares | 1.58 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics Inc | 264.53 k | 5.37 k shares | 1.40 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 261.22 k | 3.89 k shares | 1.38 | Common equity | Long | UK |
OPCH Option Care Health Inc. - Registered Shares | 250.90 k | 7.78 k shares | 1.33 | Common equity | Long | USA |
NUVL Nuvalent Inc - Ordinary Shares | 228.64 k | 2.72 k shares | 1.21 | Common equity | Long | USA |
RLAY Relay Therapeutics Inc | 224.90 k | 22.45 k shares | 1.19 | Common equity | Long | USA |
RCUS Arcus Biosciences Inc | 216.34 k | 11.31 k shares | 1.15 | Common equity | Long | USA |
First American Treasury Obligations Fund | 199.44 k | 199.44 k shares | 1.06 | Short-term investment vehicle | Long | USA |
LNTH Lantheus Holdings Inc | 198.56 k | 3.04 k shares | 1.05 | Common equity | Long | USA |
ACLX Arcellx Inc | 198.05 k | 3.01 k shares | 1.05 | Common equity | Long | USA |
MorphoSys AG
|
165.65 k | 2.36 k shares | 0.88 | Common equity | Long | Germany |
FATE Fate Therapeutics Inc | 138.48 k | 19.53 k shares | 0.73 | Common equity | Long | USA |
COGT Cogent Biosciences Inc | 126.22 k | 18.03 k shares | 0.67 | Common equity | Long | USA |
PYXS Pyxis Oncology Inc | 101.76 k | 16.00 k shares | 0.54 | Common equity | Long | USA |